Capasso Planning Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,138
Closed -$671K 128
2024
Q3
$671K Sell
4,138
-4,917
-54% -$783K 0.2% 79
2024
Q2
$1.32M Buy
9,055
+240
+3% +$35.7K 0.43% 52
2024
Q1
$1.39M Sell
8,815
-1,899
-18% -$302K 0.58% 36
2023
Q4
$1.68M Buy
10,714
+4
+0% +$613 0.78% 27
2023
Q3
$1.67M Sell
10,710
-154
-1% -$25.4K 0.89% 25
2023
Q2
$1.8M Buy
10,864
+351
+3% +$56.7K 0.97% 23
2023
Q1
$1.63M Buy
10,513
+1,778
+20% +$287K 0.96% 25
2022
Q4
$1.54M Sell
8,735
-2
-0% -$345 0.98% 25
2022
Q3
$1.43M Buy
8,737
+98
+1% +$16.6K 1% 26
2022
Q2
$1.53M Buy
8,639
+184
+2% +$32.8K 1.09% 23
2022
Q1
$1.5M Buy
8,455
+118
+1% +$20.1K 1.06% 23
2021
Q4
$1.43M Buy
+8,337
New +$1.36M 1.04% 24

Other funds holding JNJ

Capasso Planning Partners's JNJ Position: Q4 2024 in Review

Capasso Planning Partners sold out of Johnson & Johnson (JNJ) in Q4 2024, closing a stake of 4,138 shares — an estimated $671K sold.

Capasso Planning Partners first reported a position in JNJ in Q4 2021 and held it in 12 quarters. The position peaked at $1.8M in Q2 2023. 4,105 funds tracked by Wall St. Rank hold JNJ as of Q4 2024.

  • Capasso Planning Partners reported no remaining Johnson & Johnson position as of Q4 2024 after selling out during the quarter.
  • Capasso Planning Partners sold 4,138 Johnson & Johnson shares in Q4 2024, an estimated $671K.
  • Capasso Planning Partners first reported a position in Johnson & Johnson in Q4 2021 and held it in 12 quarters.
  • Capasso Planning Partners's Johnson & Johnson position peaked at $1.8M in Q2 2023.
  • 4,105 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2024.

Based on Capasso Planning Partners's 13F filing for Q4 2024, filed 10 Feb 2025.